A Phase II Trial of Bexarotene for Advanced Differentiated Thyroid Cancer
نویسندگان
چکیده
منابع مشابه
Response to neoadjuvant chemotherapy in locally advanced gastric and gastroesophageal cancer: Phase II clinical trial
Background: Gastric cancer is an important health problem across the world. Chemotherapy in combination with local treatment is standard treatment for locally advanced gastroesophageal cancers. The purpose of this investigation was evaluation of response and tolerability to neoadjuvant EOX regimen in locoregionally advanced gastric cancer. Materials and Methods: patients with locoregionally adv...
متن کاملconcurrent chemoradiotherapy without brachytherapy in locally advanced cervical cancer: a phase ii clinical trial
background and objective: concurrent chemoradiotherapy (ebrt + cisplatin) plus intracavitary brachytherapy is the standard of care in patients with advanced cervical cancer. however, some patients are unable to undergo brachytherapy due to massive residual tumor or anatomical distortion. in this study, we evaluated the treatment outcome in patients with locally advanced cervical cancer undergoi...
متن کاملI-124 pre-therapy dosimetry for the treatment of differentiated thyroid cancer: A single center experience
Introduction:The maximum tolerable activity (MTA) of I-131 in radioiodine therapy is an established surrogate quantity to ensure that the therapeutic activity does not produce severe damages to the bone marrow and lung. The aim of this study was to estimate the MTAs for high-risk patients using I-124 pre-therapy dosimetry and to compare the results with published literature. <...
متن کاملA randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for Advanced Stomach Cancer (TASC).
A randomized phase II clinical trial is being conducted for patients with advanced or recurrent gastric cancer, in order to select the most promising treatment for subsequent evaluation in a large-scale phase III trial. We compare four chemotherapeutic treatments, which include two sequential and two combination regimens using paclitaxel with 5-fluorouracil or S-1, an oral fluorouracil derivati...
متن کاملNew Insight into the Treatment of Advanced Differentiated Thyroid Cancer
The vast majority of patients with differentiated thyroid cancer (DTC) are treated successfully with surgery and radioactive iodine ablation, yet the treatment of advanced cases is frustrating and largely ineffective. Systemic treatment with conventional cytotoxic chemotherapy is basically ineffective in most patients with advanced DTC. However, a better understanding of the genetics and biolog...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Thyroid
سال: 2015
ISSN: 1050-7256,1557-9077
DOI: 10.1089/thy.2014.0399